Blend Labs Narrows Q2 Loss but Material Weaknesses Linger; Buybacks Accelerate Cash Burn

summarizeSummary

Blend Labs' Q2 2026 results show improving operating trends, but unremediated material weaknesses and aggressive share buybacks raise concerns about governance and liquidity.

check_boxKey Events · Earnings and Guidance · BLND

• Material Weaknesses Unremediated

  As of June 30, 2026, two material weaknesses in internal control over financial reporting—tied to revenue recognition and IT general controls—remain unremediated, and disclosure controls and procedures were deemed not effective.

• Q2 Financial Results

  Revenue rose 7% year-over-year to $33.8 million, while the net loss narrowed to $1.5 million from $6.8 million. Gross margin held steady at 74%.

• Cash Burn from Buybacks

  Cash and equivalents fell to $23.3 million from $45.1 million at year-end, primarily driven by $36.8 million spent on share repurchases in the first half of 2026. The buyback program still has $13.2 million authorized.

• Haveli Warrant Expired

  The Haveli Warrant, covering 11.1 million shares at $4.50, expired unexercised on April 29, 2026, eliminating a potential source of capital.

auto_awesomeAnalysis · BLND · Technology

Blend Labs posted a narrower net loss of $1.5 million on 7% higher revenue, yet two material weaknesses in internal controls over financial reporting remain unremediated. Cash and equivalents dropped to $23.3 million from $45.1 million at year-end, largely because $36.8 million was deployed for share repurchases—a substantial liquidity drain for a company with a history of cash consumption. The Haveli Warrant expired unexercised, removing a potential overhang but also a future capital source. Multiple insiders adopted or terminated 10b5-1 trading plans, a notable but routine development. For investors, the persistent control deficiencies remain the most critical risk factor.